anmelden
OMX Copenhagen 20
1.544,40
PKT
+5,93
PKT
+0,39
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Copenhagen 20-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 01.11.19 | Novo Nordisk Equal weight | Barclays Capital | |
| 01.11.19 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 01.11.19 | Novo Nordisk buy | UBS AG | |
| 01.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 28.10.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 23.10.19 | A.P. Moeller - Maersk A-S (B) Hold | Deutsche Bank AG | |
| 22.10.19 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
| 22.10.19 | A.P. Moeller - Maersk A-S (B) Equal-Weight | Morgan Stanley | |
| 21.10.19 | A.P. Moeller - Maersk A-S (B) Hold | Deutsche Bank AG | |
| 21.10.19 | Novo Nordisk buy | UBS AG | |
| 17.10.19 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
| 09.10.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.10.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 01.10.19 | A.P. Moeller - Maersk A-S (B) buy | HSBC | |
| 30.09.19 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 27.09.19 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 24.09.19 | Novo Nordisk Hold | Deutsche Bank AG | |
| 23.09.19 | Novo Nordisk Equal weight | Barclays Capital | |
| 23.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 23.09.19 | Novo Nordisk Hold | Deutsche Bank AG | |
| 23.09.19 | Novo Nordisk Reduce | HSBC | |
| 20.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 20.09.19 | Novo Nordisk Halten | Independent Research GmbH | |
| 20.09.19 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 19.09.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 13.09.19 | Novo Nordisk Neutral | Merrill Lynch & Co., Inc. | |
| 12.09.19 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 12.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 11.09.19 | A.P. Moeller - Maersk A-S (B) buy | Jefferies & Company Inc. | |
| 09.09.19 | Novo Nordisk Outperform | Bernstein Research | |
| 09.09.19 | A.P. Moeller - Maersk A-S (B) buy | Jefferies & Company Inc. | |
| 05.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 02.09.19 | Novo Nordisk buy | UBS AG | |
| 30.08.19 | A.P. Moeller - Maersk A-S (B) buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.08.19 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 29.08.19 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 28.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 20.08.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. |